STEP.De study-a multicentre cluster-randomised effectiveness trial of exercise therapy for patients with depressive symptoms in healthcare services: study protocol.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
14 04 2020
Historique:
entrez: 17 4 2020
pubmed: 17 4 2020
medline: 21 4 2021
Statut: epublish

Résumé

Although exercise therapy has widely been shown to be an efficacious treatment modality for depression, evidence for its effectiveness and cost efficiency is lacking. The Sport/Exercise Therapy for Depression study is a multicentre cluster-randomised effectiveness trial that aims to compare the effectiveness and cost efficiency of exercise therapy and psychotherapy as antidepressant treatment. 480 patients (aged 18-65) with an International Classification of Diseases diagnosis associated with depressive symptoms are recruited. Up to 30 clusters (psychotherapists) are randomly assigned to allocate patients to either an exercise or a psychotherapy treatment as usual in a 2:1 ratio. The primary outcome (depressive symptoms) and the secondary outcomes (work and social adjustment, quality of life) will be assessed at six measurement time points (t0: baseline, t1: 8 weeks after treatment initiation, t2: 16 weeks after treatment initiation, t3/4/5: 2, 6, 12 months after treatment). Linear regression analyses will be used for the primary endpoint data analysis. For the secondary endpoints, mixed linear and logistic regression models with fixed and random factors will be added. For the cost efficiency analysis, expenditures in the 12 months before and after the intervention and the outcome difference will be compared between groups in a multilevel model. Recruitment start date was 1 July 2018 and the planned recruitment end date is 31 December 2020. The study protocol was approved by the ethics committee of the University of Potsdam (No. 17/2018) and the Freie Universität Berlin (No. 206/2018) and registered in the ISRCTN registry. Informed written consent will be obtained from all participants. The study will be reported in accordance with the Consolidated Standards of Reporting Trials and the Recommendations for Interventional Trials statements. The results will be published in peer-reviewed academic journals and disseminated to the public. ISRCTN28972230.

Identifiants

pubmed: 32295779
pii: bmjopen-2019-036287
doi: 10.1136/bmjopen-2019-036287
pmc: PMC7200038
doi:

Banques de données

ISRCTN
['ISRCTN28972230']

Types de publication

Clinical Trial Protocol Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e036287

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Depress Anxiety. 2019 Jan;36(1):39-53
pubmed: 30334597
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
BMC Med. 2010 Mar 24;8:18
pubmed: 20334633
N Engl J Med. 2008 Jan 3;358(1):55-68
pubmed: 18172175
JAMA Psychiatry. 2018 Jun 1;75(6):566-576
pubmed: 29800984
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
Prev Med. 2017 Dec;105:37-46
pubmed: 28823684
BMJ. 2013 Jan 08;346:e7586
pubmed: 23303884
Eur Neuropsychopharmacol. 2011 Sep;21(9):655-79
pubmed: 21896369
J Clin Epidemiol. 1998 Nov;51(11):1171-8
pubmed: 9817135
Depress Anxiety. 2010;27(1):78-89
pubmed: 19569060
Cochrane Database Syst Rev. 2013 Oct 16;(10):CD008696
pubmed: 24129886
Physiol Behav. 2016 Mar 1;155:25-9
pubmed: 26679738
BMJ. 2015 May 08;350:h2147
pubmed: 25956159
Psychophysiology. 2013 Nov;50(11):1174-82
pubmed: 24308044
Fundam Clin Pharmacol. 2003 Aug;17(4):483-90
pubmed: 12914552
Exp Brain Res. 2017 Dec;235(12):3785-3797
pubmed: 28975416
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 May;56(5-6):885-93
pubmed: 23703510
Br J Psychiatry. 2002 May;180:461-4
pubmed: 11983645
Sports Med. 2016 May;46(5):699-713
pubmed: 26707338
J Consult Clin Psychol. 2008 Dec;76(6):966-78
pubmed: 19045965
PLoS Med. 2009 Jul 21;6(7):e1000100
pubmed: 19621070
J Pers Soc Psychol. 2003 Apr;84(4):822-48
pubmed: 12703651
Lancet. 2016 Oct 8;388(10053):1545-1602
pubmed: 27733282
Lancet. 2007 Dec 1;370(9602):1875-7
pubmed: 17959239
Br J Math Stat Psychol. 2013 Feb;66(1):103-26
pubmed: 22420323
BMJ. 1998 Jan 24;316(7127):285
pubmed: 9472515
Front Psychiatry. 2018 Jul 19;9:305
pubmed: 30072923
J Psychiatr Res. 2016 Jun;77:42-51
pubmed: 26978184
Cochrane Database Syst Rev. 2013 Sep 12;(9):CD004366
pubmed: 24026850
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
J Clin Nurs. 2010 Apr;19(7-8):1102-12
pubmed: 20492055
Br J Psychiatry. 2002 Jan;180:13-8
pubmed: 11772845
J Aging Phys Act. 2019 Nov 7;:1-11
pubmed: 31711036
Eur Psychiatry. 2018 Oct;54:124-144
pubmed: 30257806
Depress Anxiety. 2013 Nov;30(11):1068-83
pubmed: 23922209
Psychosoc Med. 2013;10:Doc01
pubmed: 23429426
J Neurosci. 2013 Mar 20;33(12):5301-11
pubmed: 23516294
Clin Psychol Rev. 2007 Dec;27(8):959-85
pubmed: 17448579
Bull World Health Organ. 2010 Nov 1;88(11):815-23
pubmed: 21076562
J Sci Med Sport. 2014 Mar;17(2):177-82
pubmed: 23602562
Eur Psychiatry. 2007 Jan;22(1):1-8
pubmed: 17194571
Trials. 2014 Jan 21;15:29
pubmed: 24447460
Br J Psychiatry. 2016 Nov;209(5):414-420
pubmed: 27609813
J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62
pubmed: 14399272
BMJ. 2012 Sep 04;345:e5661
pubmed: 22951546
Epidemiol Psychiatr Sci. 2019 Jun;28(3):268-274
pubmed: 30058524
Clin Trials. 2018 Feb;15(1):53-64
pubmed: 28905640
Epidemiol Psychiatr Sci. 2019 Feb;28(1):21-30
pubmed: 29486804
Int J Behav Nutr Phys Act. 2011 Oct 21;8:115
pubmed: 22018588
JAMA. 2012 Dec 26;308(24):2594-604
pubmed: 23268518
Phys Ther. 2003 Aug;83(8):713-21
pubmed: 12882612
BMJ. 2001 Mar 31;322(7289):763-7
pubmed: 11282860
Sports Med. 2009;39(6):491-511
pubmed: 19453207
Lancet. 2016 Aug 27;388(10047):871-80
pubmed: 27461440
Acta Neuropsychiatr. 2017 Apr;29(2):65-71
pubmed: 27145824
BMJ. 2000 Dec 2;321(7273):1389-92
pubmed: 11099285
BMJ. 2008 Nov 11;337:a2390
pubmed: 19001484

Auteurs

Andreas Heissel (A)

Social and Preventive Medicine, Department Sport and Health Sciences, Faculty of Human Sciences, University of Potsdam, Potsdam, Brandenburg, Germany andreas.heissel@uni-potsdam.de.

Anou Pietrek (A)

Social and Preventive Medicine, Department Sport and Health Sciences, Faculty of Human Sciences, University of Potsdam, Potsdam, Brandenburg, Germany.

Melanie Schwefel (M)

Social and Preventive Medicine, Department Sport and Health Sciences, Faculty of Human Sciences, University of Potsdam, Potsdam, Brandenburg, Germany.

Kahar Abula (K)

Social and Preventive Medicine, Department Sport and Health Sciences, Faculty of Human Sciences, University of Potsdam, Potsdam, Brandenburg, Germany.

Gregor Wilbertz (G)

Department of Education and Psychology, Freie Universität Berlin, Berlin, Germany.

Stephan Heinzel (S)

Department of Education and Psychology, Freie Universität Berlin, Berlin, Germany.

Michael Rapp (M)

Social and Preventive Medicine, Department Sport and Health Sciences, Faculty of Human Sciences, University of Potsdam, Potsdam, Brandenburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH